Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
MOMOLBIO.NSthis companyMolbio Diagnostics Limited	₹1,336.00	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
3BBLACKBIO.BO3B BlackBio Dx Ltd	₹1,288.35	16.05×	2.89×	6.61×	14.8×	21.4%	54.2%	36.4%	41.3%	18.1%	11.8%	2.9%	0.01×	-1.72×	217.84×	5.27×	0.4%	—	—	2	C+
KRSNAA.NSKrsnaa Diagnostics Limited	₹493.60	16.62×	1.72×	2.18×	8.58×	-320.3%	39.0%	15.7%	13.1%	10.3%	5.9%	-5.6%	0.55×	1.98×	3.53×	2.68×	0.5%	3	—	2	B-
LALPATHLAB.NSDr. Lal PathLabs Limited	₹2,016.50	43.39×	8.73×	7.93×	25.61×	4.3%	42.0%	22.5%	18.3%	20.1%	16.9%	2.4%	0.08×	-0.05×	27.22×	3.48×	1.0%	4	—	2	C+
METROPOLIS.NSMetropolis Healthcare Limited	₹582.35	47.23×	5.93×	5.45×	21.92×	69.1%	47.8%	16.2%	11.5%	12.6%	10.4%	3.3%	0.15×	0.42×	10.88×	1.4×	0.2%	4	—	2	C+
SURAKSHA.NSSuraksha Diagnostic Ltd.	₹350.40	36.89×	4.85×	3.82×	13.47×	-74.2%	57.7%	17.5%	10.4%	13.1%	9.5%	1.4%	0.53×	1.08×	4.33×	1.05×	0.0%	5	—	2	C
Peer median	—	36.89×	4.85×	5.45×	14.8×	4.3%	47.8%	17.5%	13.1%	13.1%	10.4%	2.4%	0.15×	0.42×	10.88×	2.68×	0.4%	4	—	2	—